YU Wan-qing, CHEN Chao, YANG Ya-xi, ZHI Ying, ZHOU Bing. Advances in drug research targeting ubiquitin-specific protease 7J. Acta Pharmaceutica Sinica, 2025, 60(8): 2453-2465. DOI: 10.16438/j.0513-4870.2024-1048
Citation: YU Wan-qing, CHEN Chao, YANG Ya-xi, ZHI Ying, ZHOU Bing. Advances in drug research targeting ubiquitin-specific protease 7J. Acta Pharmaceutica Sinica, 2025, 60(8): 2453-2465. DOI: 10.16438/j.0513-4870.2024-1048

Advances in drug research targeting ubiquitin-specific protease 7

  • Ubiquitin-specific protease 7 (USP7) is one of the more widely studied members of the deubiquitinating enzyme family, which regulates the activity and function of a variety of proteins in cells. USP7 is closely associated with the tumor progression, which makes USP7 a highly promising target for drug therapy. However, no drug targeting USP7 has yet been approved for clinical trials, thus the development of drug targeting USP7 still requires in-depth research. This article reviews the structure and function of USP7 and the progress of drug research targeting USP7.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return